Large-scale testing (Phase 3)Study completedNCT02780141
What this trial is testing
Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia
Who this might be right for
ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc 75